THANOSWITCH Trademark

Trademark Overview


On Wednesday, May 5, 2021, a trademark application was filed for THANOSWITCH with the United States Patent and Trademark Office. The USPTO has given the THANOSWITCH trademark a serial number of 90692260. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, December 25, 2023. This trademark is owned by Inzen Therapeutics, Inc.. The THANOSWITCH trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical agents and products for cellular signal modulation for treating cancer, fibrotic diseases, immune and inflammatory diseases, neurological diseases, infectious disease, tissue degenerative diseases, regenerative medicine; therapeutic products for cellular signal modulation in the nature of chemical and biological small molecules for medical use, for treating cancer, fibrotic diseases, immune and inflammatory diseases, neurological diseases, infectious disease, tissue degenerative diseases, regenerative medicine; pharmaceutical compositions in the nature of chemical and biological small molecules for treatment of cancer, fibrotic diseases, immune and inflammatory diseases, neurological diseases, infectious disease, tissue degenerative diseases, regenerative medicine; pharmaceutical compositions in the nature of chemical and biological molecules for cellular signal modulation for treating cancer, fibrotic diseases, immune and inflammatory diseases, neurological diseases, in...

Scientific research, pharmaceutical research, and medical research in the fields of pharmaceutical research and development and biotechnology for others; product development for others in the field of biotechnology; development of pharmaceuticals and therapeutic agents for others
thanoswitch

General Information


Serial Number90692260
Word MarkTHANOSWITCH
Filing DateWednesday, May 5, 2021
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, December 25, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 28, 2023

Trademark Statements


Goods and ServicesPharmaceutical agents and products for cellular signal modulation for treating cancer, fibrotic diseases, immune and inflammatory diseases, neurological diseases, infectious disease, tissue degenerative diseases, regenerative medicine; therapeutic products for cellular signal modulation in the nature of chemical and biological small molecules for medical use, for treating cancer, fibrotic diseases, immune and inflammatory diseases, neurological diseases, infectious disease, tissue degenerative diseases, regenerative medicine; pharmaceutical compositions in the nature of chemical and biological small molecules for treatment of cancer, fibrotic diseases, immune and inflammatory diseases, neurological diseases, infectious disease, tissue degenerative diseases, regenerative medicine; pharmaceutical compositions in the nature of chemical and biological molecules for cellular signal modulation for treating cancer, fibrotic diseases, immune and inflammatory diseases, neurological diseases, infectious disease, tissue degenerative diseases, regenerative medicine
Pseudo MarkTHANO SWITCH
Goods and ServicesScientific research, pharmaceutical research, and medical research in the fields of pharmaceutical research and development and biotechnology for others; product development for others in the field of biotechnology; development of pharmaceuticals and therapeutic agents for others

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, July 8, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, July 8, 2022
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameSONATA THERAPEUTICS, INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCAMBRIDGE, MA 02142

Party NameSONATA THERAPEUTICS, INC.
Party Type11 - New Owner Before Publication
Legal Entity Type03 - Corporation
AddressCAMBRIDGE, MA 02142

Party NameInzen Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142

Trademark Events


Event DateEvent Description
Tuesday, December 26, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, December 25, 2023ABANDONMENT - NO USE STATEMENT FILED
Tuesday, May 23, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, March 28, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 28, 2023PUBLISHED FOR OPPOSITION
Wednesday, March 8, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, February 23, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, February 7, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, February 6, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, February 6, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, January 4, 2023AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Monday, August 8, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, August 8, 2022NON-FINAL ACTION E-MAILED
Monday, August 8, 2022NON-FINAL ACTION WRITTEN
Friday, July 8, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, July 8, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, July 8, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, January 11, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, January 11, 2022NON-FINAL ACTION E-MAILED
Tuesday, January 11, 2022NON-FINAL ACTION WRITTEN
Thursday, January 6, 2022ASSIGNED TO EXAMINER
Friday, August 6, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED